Baylor Scott & White Health’s Post

Announcing the first ever class of Modern Healthcare's 40 Under 40! Read the profiles of the exceptional young executives we selected and learn about their indelible impact on their organizations, the patients and communities they serve and the future of healthcare. View the Honorees: https://ow.ly/l9FX50QAHVa

💡 New Expert Exchange Dr. Alex Chiu, University of Kansas Medical Center, shares his insight and experience on the importance of trust in the doctor-patient relationship. "I very quickly understood that there is great trust in healthcare providers here," said Dr. Alex Chiu, "but that trust needs to be earned, not expected." Stay tuned for more insights from Dr. Chiu and other leaders in the healthcare industry featured on the Expert Exchange series. https://lnkd.in/gp2TUQ34

Here’s a 2024 #Healthcare Prediction from Greg Samios, President and CEO of Clinical Effectiveness at Wolters Kluwer Health: We predict as healthcare explores #GenAI and patient care, the source and vetting of the underlying content will become a key factor in the speed in which it is deployed. https://lnkd.in/eAcHSZNR

Congratulations to Jonathan B. Perlin, MD, PhD, MSHA, MACP, FACMI, President and Chief Executive Officer, The Joint Commission Enterprise, who was named to Modern Healthcare’s 100 Most Influential People in Healthcare for the second year in a row. Learn more about Dr. Perlin's accomplishments and future vision for The Joint Commission Enterprise: https://lnkd.in/edbDtJsv #MH100Most

Here’s a 2024 #Healthcare Prediction from Greg Samios, President and CEO of Clinical Effectiveness at Wolters Kluwer Health: We predict as healthcare explores #GenAI and patient care, the source and vetting of the underlying content will become a key factor in the speed in which it is deployed. https://lnkd.in/eJh2RK6r

R E C A P ⏪ Here's a recap of some key takeaways from our conversation with Dr. Sergio Meneses Navarro regarding public healthcare challenges and equitable access to healthcare in Latin America. Read more or watch the full interview here https://lnkd.in/eMSKkvqc

⚠️ Do NOT miss this on-demand webinar that tells the nonfictional story of our impending healthcare crisis. An absolute must see for anyone in healthcare leadership, policy-making, education, or practice. https://hubs.li/Q02shPmq0 #FutureOfHealthcare

Here’s a 2024 #Healthcare Prediction from Greg Samios, President and CEO of Clinical Effectiveness at Wolters Kluwer Health: We predict as healthcare explores #GenAI and patient care, the source and vetting of the underlying content will become a key factor in the speed in which it is deployed. https://lnkd.in/gMkaPNsd

Questions about whether to use AI in healthcare are long gone. The new question is *how* to use intelligent technology in this industry. Don't miss this opportunity to hear first-hand how leaders across healthcare are leveraging AI, and where they're investing to make the most impact.

Calling all Investors who are committed to seeing their support drive innovation in the making of medicines of the future: The Future is Now! Please join our CEO, Steven Kelly as he presents the progress & pipeline of Carisma Therapeutics! Q&A session will follow. Mark your calendars for January 11th 2024 8:15am US ET to attend the WebCast here: https://lnkd.in/ejB_DSc2 or Register to attend in-person in San Francisco here: https://lnkd.in/eVAKvK-B "We are leveraging the natural power of monocytes and macrophages by engineering them to attack tumors. CAR-Macrophages (chimeric antigen receptor macrophages) can eat away at tumors and lead to long-term anti-tumor immunity, giving patients a promising new long term strategy in the fight against cancer." In the meanwhile, follow Carisma traded on the Nasdaq Stock Market LLC under the ticker symbol “CARM”. Additional information found here: https://lnkd.in/ehqQVygQ #investors #innovationinhealthcare #macrophages #immunooncology #pivotal #convergence #personalization #scientificinnovation #expansion #resilience #transformativetech #emerging #medicines